December 18, 2024

USPSTF Challenges Common Supplement Use

"Unfortunately, when we reviewed the latest evidence, we found that taking vitamin D with or without calcium does not prevent falls or fractures in older adults."

Conexiant

December 18, 2024

Physicians With Kids Face Large Pay Gaps

Physician compensation remains a central concern in health care, influenced by educational debt, specialty-specific variations, and evolving employer policies.

Conexiant

December 16, 2024

Walking Away from Depression: Large Study

New meta-analysis of 96,173 adults finds each additional 1,000 daily steps associated with 9% lower depression risk, with benefits starting at just 5,000 steps per day.

Conexiant

December 16, 2024

Study Finds New Sexual Transmission Disease Risks

Review expands list of viruses persisting in human semen from 9 to 22.

Conexiant

December 16, 2024

New Drug Cuts Steroid Need in CAH

The FDA has approved crinecerfont (Crenessity) to manage androgen levels in classic congenital adrenal hyperplasia in individuals aged 4 or older. Find out more at FDA.

Conexiant

December 13, 2024

UnitedHealth Group CEO Acknowledges ‘Flawed’ System

"No one would design a system like the one we have. And no one did. It's a patchwork built over decades."

Reuters

December 13, 2024

CMS Mandates Qalsody Coverage in Medicare Plans

CMS directs insurers to cover Biogen's ALS drug Qalsody, overturning coverage denial labeled as 'experimental and investigational.' The ALS Association partners with CMS to address unjust coverage denials, urging affected individuals to seek access to treatment.

Reuters

December 12, 2024

Melanoma Recurrence Signs with ATLAS Guide

Study published in the Journal of the American Academy of Dermatology explores key symptoms and detection strategies for melanoma recurrence, providing potential improvements for surveillance protocols.

Conexiant

December 12, 2024

Is Bausch + Lomb Facing a Sale?

Bausch + Lomb, a major eye-care company, is exploring a potential sale in response to a request from the Canadian Investment Regulatory Organization (CIRO) due to media reports on likely sale triggering volatility in its shares.

Reuters